• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 TCGA SpliceSeq 数据鉴定肾上腺皮质癌中与生存相关的可变剪接事件和特征。

Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.

机构信息

Departments of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.

出版信息

Aging (Albany NY). 2020 Mar 26;12(6):4996-5009. doi: 10.18632/aging.102924.

DOI:10.18632/aging.102924
PMID:32217810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7138552/
Abstract

OBJECTIVE

To explore the correlations among alternative splicing (AS), splicing factors (SF) and survival outcome in adrenocortical carcinoma (ACC) patients.

RESULTS

A total of 92 ACC patients were included. Univariate analysis identified 3919 AS events significantly associated with overall survival. Lasso method followed by multivariate analysis revealed that the prognostic capacity of these survival-related AS events is satisfactory. Interestingly, we found that the area under the curve (AUC) of AA, AD, AP and RI were more than 0.9, indicating that these four types of AS were of great significance. Independent prognostic analysis showed that only the risk score was the independent risk factor of ACC survival. Finally, we constructed an interesting interaction network between AS and SF.

CONCLUSIONS

This is the first and most comprehensive study to explore the aberrant AS variants in ACC, which might provide novel insights into molecular mechanism of ACC.

METHODS

The transcriptome data, clinical information and Percent Spliced In (PSI) values of the ACC were obtained from TCGA database and TCGA SpliceSeq data portal. Lasso method and uni/multivariate Cox regression analysis were used to identify survival-related AS events and develop multi-AS-based signatures. The relationship between AS events and SFs was also investigated.

摘要

目的

探讨肾上腺皮质癌(ACC)患者中可变剪接(AS)、剪接因子(SF)与生存结局的相关性。

结果

共纳入 92 例 ACC 患者。单因素分析确定了 3919 个与总生存显著相关的 AS 事件。Lasso 法和多因素分析进一步揭示了这些与生存相关的 AS 事件具有良好的预后预测能力。有趣的是,我们发现 AA、AD、AP 和 RI 的曲线下面积(AUC)均大于 0.9,提示这四种 AS 类型具有重要意义。独立预后分析表明,只有风险评分是 ACC 生存的独立危险因素。最后,我们构建了一个有趣的 AS 与 SF 之间的互作网络。

结论

这是首个也是最全面的探讨 ACC 中异常 AS 变异的研究,可能为 ACC 的分子机制提供新的见解。

方法

从 TCGA 数据库和 TCGA SpliceSeq 数据门户获取了 ACC 的转录组数据、临床信息和 PSI 值。采用 Lasso 法和单/多因素 Cox 回归分析筛选与生存相关的 AS 事件,并构建基于多 AS 的预后模型。还研究了 AS 事件与 SF 之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/cfb8b2095c1b/aging-12-102924-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/3cd6a4169c36/aging-12-102924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/83ca7b3e0022/aging-12-102924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/5d02054f2e66/aging-12-102924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/b10b98be8d17/aging-12-102924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/1ac12c86382a/aging-12-102924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/13e4876b2996/aging-12-102924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/b02d621aeedf/aging-12-102924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/cfb8b2095c1b/aging-12-102924-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/3cd6a4169c36/aging-12-102924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/83ca7b3e0022/aging-12-102924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/5d02054f2e66/aging-12-102924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/b10b98be8d17/aging-12-102924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/1ac12c86382a/aging-12-102924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/13e4876b2996/aging-12-102924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/b02d621aeedf/aging-12-102924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7046/7138552/cfb8b2095c1b/aging-12-102924-g008.jpg

相似文献

1
Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.基于 TCGA SpliceSeq 数据鉴定肾上腺皮质癌中与生存相关的可变剪接事件和特征。
Aging (Albany NY). 2020 Mar 26;12(6):4996-5009. doi: 10.18632/aging.102924.
2
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.肾上腺皮质癌中预后相关的 mRNA 剪接变异。
Front Endocrinol (Lausanne). 2021 Mar 12;12:538364. doi: 10.3389/fendo.2021.538364. eCollection 2021.
3
Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.基于生物信息学方法鉴定肾上腺皮质癌微环境中的预后基因。
Cancer Med. 2020 Feb;9(3):1161-1172. doi: 10.1002/cam4.2774. Epub 2019 Dec 19.
4
Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.m6A RNA 甲基化调控因子在肾上腺皮质癌进展和预后中的作用的生物信息学分析和实验验证。
Aging (Albany NY). 2021 Apr 21;13(8):11919-11941. doi: 10.18632/aging.202896.
5
Characterization of alternative splicing events and prognostic signatures in breast cancer.乳腺癌中可变剪接事件和预后特征的分析。
BMC Cancer. 2021 May 22;21(1):587. doi: 10.1186/s12885-021-08305-6.
6
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.基于 m6A RNA 甲基化调控因子的签名构建与验证:用于预测肾上腺皮质癌患者预后
Front Endocrinol (Lausanne). 2021 Feb 22;12:568397. doi: 10.3389/fendo.2021.568397. eCollection 2021.
7
Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.口腔鳞状细胞癌中预后性可变剪接标志的鉴定。
J Cell Physiol. 2020 May;235(5):4804-4813. doi: 10.1002/jcp.29357. Epub 2019 Oct 21.
8
Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.通过转录组分析鉴定 NDRG 家族成员 4(NDRG4)和 CDC28 蛋白激酶调节亚基 2(CKS2)为肾上腺皮质癌的关键预后基因。
Med Sci Monit. 2021 Mar 5;27:e928523. doi: 10.12659/MSM.928523.
9
Genome-wide profiling of alternative splicing in glioblastoma and their clinical value.脑胶质瘤中可变剪接的全基因组分析及其临床价值。
BMC Cancer. 2021 Aug 26;21(1):958. doi: 10.1186/s12885-021-08681-z.
10
Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.胰腺导管腺癌中与生存相关的可变剪接信使 RNA 特征:基于 RNA 测序数据的研究。
DNA Cell Biol. 2019 Nov;38(11):1207-1222. doi: 10.1089/dna.2019.4862. Epub 2019 Sep 4.

引用本文的文献

1
Identification of the ferroptosis regulator HELLS with prognostic value for adrenocortical carcinoma based on integrated analysis and experimental validation.基于综合分析和实验验证鉴定出对肾上腺皮质癌具有预后价值的铁死亡调节因子HELLS
Gland Surg. 2023 Sep 25;12(9):1251-1270. doi: 10.21037/gs-22-736. Epub 2023 Sep 15.
2
Systematic Genome-Wide Profiles Reveal Alternative Splicing Landscape and Implications of Splicing Regulator DExD-Box Helicase 21 in Aggressive Progression of Adrenocortical Carcinoma.全基因组系统分析揭示肾上腺皮质癌侵袭性进展中的可变剪接图谱及剪接调节因子DExD盒解旋酶21的影响。
Phenomics. 2021 Oct 29;1(6):243-256. doi: 10.1007/s43657-021-00026-x. eCollection 2021 Dec.
3

本文引用的文献

1
Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.系统分析可变剪接特征揭示宫颈癌的预后预测因子。
J Transl Med. 2019 Nov 19;17(1):379. doi: 10.1186/s12967-019-02140-x.
2
Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.乳腺癌中预后性可变剪接特征的鉴定
Front Genet. 2019 Mar 28;10:278. doi: 10.3389/fgene.2019.00278. eCollection 2019.
3
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art.米托坦在肾上腺皮质癌中的作用——综述与现状
Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
鉴定免疫相关基因特征作为肾上腺皮质癌的预后靶点和免疫微环境。
Immun Inflamm Dis. 2022 Sep;10(9):e680. doi: 10.1002/iid3.680.
4
Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction.用于结肠癌预后预测的筛选基因表达相关可变剪接事件特征
J Oncol. 2022 Jan 27;2022:9952438. doi: 10.1155/2022/9952438. eCollection 2022.
5
Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.基于TCGA剪接序列数据的食管癌可变剪接事件的预后特征
Front Oncol. 2021 Oct 5;11:658262. doi: 10.3389/fonc.2021.658262. eCollection 2021.
6
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021.2019-2021 年肾上腺皮质癌的分子基因分型:文献系统分析。
Curr Opin Oncol. 2022 Jan 1;34(1):19-28. doi: 10.1097/CCO.0000000000000799.
7
Identification of an alternative splicing signature as an independent factor in colon cancer.鉴定剪接变异标志作为结肠癌的一个独立因素。
BMC Cancer. 2020 Sep 22;20(1):904. doi: 10.1186/s12885-020-07419-7.
Eur Endocrinol. 2018 Sep;14(2):62-66. doi: 10.17925/EE.2018.14.2.62. Epub 2018 Sep 10.
4
Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane.Hsp90 抑制在肾上腺皮质癌中的作用:米托坦与药物协同作用有限。
Mol Cell Endocrinol. 2019 Jan 15;480:36-41. doi: 10.1016/j.mce.2018.10.009. Epub 2018 Oct 10.
5
Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.成人局限性/局部进展期原发性肾上腺皮质癌(ENSAT I - III期)的腹腔镜与开放性肾上腺切除术:无瘤切缘是决定手术结果的关键因素吗?文献综述
J Laparoendosc Adv Surg Tech A. 2018 Apr;28(4):408-414. doi: 10.1089/lap.2017.0546. Epub 2018 Jan 10.
6
The Expanding Landscape of Alternative Splicing Variation in Human Populations.人类群体中可变剪接变异的扩展景观。
Am J Hum Genet. 2018 Jan 4;102(1):11-26. doi: 10.1016/j.ajhg.2017.11.002.
7
The Functional Impact of Alternative Splicing in Cancer.可变剪接在癌症中的功能影响
Cell Rep. 2017 Aug 29;20(9):2215-2226. doi: 10.1016/j.celrep.2017.08.012.
8
Alternative splicing as a regulator of development and tissue identity.可变剪接作为发育和组织特性的调节因子。
Nat Rev Mol Cell Biol. 2017 Jul;18(7):437-451. doi: 10.1038/nrm.2017.27. Epub 2017 May 10.
9
HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of during epithelial-mesenchymal transition.HNRNPLL,一种新鉴定的结直肠癌转移抑制因子,调节上皮-间充质转化过程中 的可变剪接。
Gut. 2018 Jun;67(6):1103-1111. doi: 10.1136/gutjnl-2016-312927. Epub 2017 Mar 30.
10
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.SF3B3 通过剪接 EZH2 前体 mRNA 促进肾癌的致瘤潜能。
Clin Cancer Res. 2017 Jul 1;23(13):3428-3441. doi: 10.1158/1078-0432.CCR-16-2020. Epub 2016 Nov 22.